GlassScriptPhysician profile
Celeste Crna Fleming
NPI 1184875569
$3,778.03
in general payments reported to CMS, 2019-2025
23 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $805 · 2023: $952 · 2024: $1,003 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693 · Travel and Lodging: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.59 |
| Travel and Lodging | $840.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,422.90 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $511.95 | 2021-2025 | Jetstream Sc, General - Vascular Intervention |
| Medtronic, INC. | $426.16 | 2022-2025 | Endurant Iis, Venaseal, Valiant Captivia |
| Baxter Healthcare | $273.44 | 2021-2022 | |
| Veryan Medical Incorporated | $166.48 | 2022 | |
| Organogenesis INC. | $123.03 | 2022 | |
| Paratek Pharmaceuticals, INC. | $120.34 | 2025 | Nuzyra |
| Tactile Systems Technology INC | $120.32 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbott Laboratories | $80.35 | 2021-2024 | Absolute Pro |
| Janssen Pharmaceuticals, INC | $67.30 | 2021-2022 | |
| Convatec INC. | $65.04 | 2021-2025 | |
| Philips North America LLC | $53.58 | 2021-2023 | |
| Lemaitre Vascular, INC. | $50.73 | 2022-2024 | Restoreflow, Hydro Lemaitre Valvulotome |
| Ossur Americas, INC. | $43.77 | 2025 | |
| Pfizer INC. | $40.33 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $37.81 | 2021-2025 | Rotarexs 6 F X 135 Cm |
| Bioventus LLC | $36.85 | 2022-2023 | |
| W. L. Gore & Associates, INC. | $36.58 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Polynovo North America LLC | $31.28 | 2025 | Novosorb Btm |
| Kci USA, INC. | $19.16 | 2021 | |
| Angiodynamics, INC. | $19.11 | 2021 | |
| Kerecis Limited | $18.89 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Biowound Solutions, INC. | $12.63 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celeste Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.